William G. Wierda - Researcher Profile

Publications

2 shown

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

Enli Liu , David Marín , Pinaki P. Banerjee +24 more

Among 11 patients with relapsed or refractory CD19-positive cancers, a majority had a response to treatment with CAR-NK cells without the development of major toxic effects. (Fu...

2020 New England Journal of Medicine 1930 citations

Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia

Lorenzo Falchi , Michael J. Keating , Edith M. Marom +12 more

Key Points Histologically aggressive CLL differs from histologically indolent CLL. Patients with different CLL phases but similar SUVmax have similar outcomes. FDG/PET is a usef...

2014 Blood 144 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 2,074
Institution: The University of Texas MD Anderson Cancer Center

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-7357-270X

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.